ArticleAntimicrobial agents and chemotherapy2022

Activity of Oritavancin against Gram-Positive Pathogens Causing Bloodstream Infections in the United States over 10 Years: Focus on Drug-Resistant Enterococcal Subsets (2010-2019).

Cecilia G Carvalhaes et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.